<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="370376">
  <stage>Registered</stage>
  <submitdate>22/03/2016</submitdate>
  <approvaldate>6/05/2016</approvaldate>
  <actrnumber>ACTRN12616000589482</actrnumber>
  <trial_identification>
    <studytitle>Extracorporeal shock wave therapy (ESWT) and kinesiotherapy (KIN) on women with bilateral knee osteoarthritis</studytitle>
    <scientifictitle>The investigation of the effects of extracorporeal shock wave therapy (ESWT) and kinesiotherapy (KIN) on health status of women with bilateral knee osteoarthritis (OA):               a  randomised trial </scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>knee pain</healthcondition>
    <healthcondition>osteoarthritis</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Osteoarthritis</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Physical Medicine / Rehabilitation</conditioncode1>
      <conditioncode2>Physiotherapy</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>ESWT - 1,000 pulses (during the first treatment), 1,500 (during the second and the third treatment), and 2,000 (during the fourth and the fifth treatment), respectively (pressure, 2.5 bar; frequency, 8 Hz; energy density, 0.4 mJ/mm2).  ESWT - 1 treatment per week. Each treatment session will not exceed 10 minutes. Intervention will be delivered by a physiotherapist
KIN - 25 sessions of a physiotherapy program  an hour a day, 5 days a week, for 5 weeks. Intervention will be delivered by a physiotherapist. The mode of delivery as face to face, The intervention will be provided individually. The Kinesiotherapy program: 1. Warm-up. 2. Stretching. 3. Strengthening. 4. Functional task-oriented training. 5. Endurance. 6. Cool down. Examples of exercises for all participants in Kin group: 1. Global flexion-extension of the lower limb. Alternated dorsal  plantar  flexion of the ankles. 2.  Stretching of the hamstrings. 3. Isometric knee extensors: flex 0 degrees. Isometric knee extensors: flex 60 degrees. Isometric  hamstrings: flex 60 degrees. Concentric-eccentric hip abductors.  4. Knee extensor strengthening while standing  with Thera-Band.  Controlled bilateral knee flexion-extension while standing . Climbing on a platform or a flight of stairs.  Walking in place, with a large amplitude of hip and knee flexion and upper-limb movements. 5. Stationary cycling. 6. Ice for quadriceps, hamstrings, and calf. Intervention will be administered in physiotherapy department, Log of sessions attended will be maintained.  Participants will never receive both intervention, two separate groups will receive only one intervention - ESWT or KIN.</interventions>
    <comparator>KiN - control </comparator>
    <control>Active</control>
    <interventioncode>Treatment: Devices</interventioncode>
    <interventioncode>Rehabilitation</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>the Western Ontario and McMaster Universities Questionnaire (WOMAC) Osteoarthritis Index</outcome>
      <timepoint>before treatment starts
at 5 weeks after randomisation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>knee pain assessed using a 10 cm Visual Analogue Scale (VAS)</outcome>
      <timepoint>baseline and 5 weeks after treatment starts</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>the Six-Minute Walk Test (6-MWT) was performed to evaluate functional exercise capacity in a 100 m-long indoor hallway free of obstacles </outcome>
      <timepoint>baseline and 5 weeks after treatment starts, </timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>knee flexion range of painless movement.  This outcome will be assessed using goniometer (MSD Europe bvba, Londerzeel, Belgium)</outcome>
      <timepoint>baseline and 5 weeks after treatment starts</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>knee extension range of painless movement. This outcome will be assessed using goniometer (MSD Europe bvba, Londerzeel, Belgium)</outcome>
      <timepoint>baseline and 5 weeks after treatment starts</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>female gender,  minimum age of 40, ability to perform physical exercises, not currently receiving any physical therapy treatments for the knee OA condition, medication compliance (all patients were taking glucocorticoids at the time of the study), and the diagnosis of bilateral knee OA according to the American College of Rheumatology criteria</inclusivecriteria>
    <inclusiveminage>40</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>unilateral knee OA, neurological disorders, cognitive limitations or history of cardiovascular, pulmonary or endocrinology disease</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate />
    <actualstartdate>2/11/2015</actualstartdate>
    <anticipatedenddate />
    <actualenddate>21/03/2016</actualenddate>
    <samplesize>60</samplesize>
    <actualsamplesize>60</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate>20/06/2016</anticipatedlastvisitdate>
    <actuallastvisitdate>20/06/2016</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Silesia</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Holycross College</primarysponsorname>
    <primarysponsoraddress>51, Mielczarskiego Str.
25-709 Kielce</primarysponsoraddress>
    <primarysponsorcountry>Poland</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Holycross College</fundingname>
      <fundingaddress>51, Mielczarskiego Str.
25-709 Kielce</fundingaddress>
      <fundingcountry>Poland</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Despite the advances in treatment there is lack of comparative studies on the effects of ESWT and other treatments such as KIN in patients with knee OA.
Objectives of Study: to compare the effects of ESWT and KIN protocol on perceived health evaluated by the Western Ontario and McMaster Universities Questionnaire (WOMAC) Osteoarthritis Index, on severity of knee pain by Visual Analogue Scale (VAS), on Range of Motion (ROM) of the knees and also on functional exercise capacity by the Six-Minute Walk Test (6-MWT) physical function, decreased exercise capacity).
</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The Holycross College Ethics Committee </ethicname>
      <ethicaddress>51, Mielczarskiego Str.
25-709 Kielce</ethicaddress>
      <ethicapprovaldate>22/10/2015</ethicapprovaldate>
      <hrec>11/152014KB</hrec>
      <ethicsubmitdate>1/10/2015</ethicsubmitdate>
      <ethiccountry>Poland</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Pawel Lizis</name>
      <address>Pawel Lizis
Holycross College
51, Mielczarskiego Str.
25-709 Kielce

Wojciech Kobza
Bielski College named after Tyszkiewicz
12, Nadbrzezna Str.
43-300 Bielsko-Biala
</address>
      <phone>+48663793834</phone>
      <fax />
      <email>pawel_lizis@poczta.onet.pl</email>
      <country>Poland</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Pawel Lizis</name>
      <address>Pawel Lizis
Holycross College
51, Mielczarskiego Str.
25-709 Kielce</address>
      <phone>+48663793834</phone>
      <fax />
      <email>pawel_lizis@poczta.onet.pl</email>
      <country>Poland</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Pawel Lizis</name>
      <address>Pawel Lizis
Holycross College
51, Mielczarskiego Str.
25-709 Kielce</address>
      <phone>+48663793834</phone>
      <fax />
      <email>pawel_lizis@poczta.onet.pl</email>
      <country>Poland</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Pawel Lizis</name>
      <address>51, Mielczarskiego Str.
25-709 Kielce</address>
      <phone>+48663793834</phone>
      <fax />
      <email>pawel_lizis@poczta.onet.pl</email>
      <country>Poland</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>